Gapping up
In reaction to strong earnings/guidance: AEO +11.7%, ZPIN +10.2%, LITB +6.1%, HAIN +4.1%, GLOG +3.6%, EJ +3.5%, EJ +3.5%, SPLS +3.3%, PETM +3.2%, EV +1.7%,.
M&A news: FCS +3.9% (reports Infineon (IFNNY) may be looking to acquire US co, no company mentioned), TMUS +0.7% (Iliad SA (ILIAY) seeks help to make another TMUS bid, according to NYPost).
Select metals/mining stocks trading higher: BHP +1.2%, GFI +1.2%, HK +1.1%, RIO +0.9%.
Other news: FOLD +20.4% (announces positive Phase 3 data From Fabry Monotherapy study), DGLY +12.3% (following 90%+ move higher yesterday; attributed to police body camera demand), PETM +3.2% (announced acquisition of Pet360; announced exploration of strategic alternatives; co also reported earnings), CVV +3.2% (co receives an order in excess of $2.75 mln from a major aviation component supplier to design and build a CVD system for coating fiber), LRAD +3.1% (may be body camera related play, TASR and DGLY have also made notable upside moves recently), EXXI +2.5% (positve commentary on Mad Money), SEAS +2.2% (PETA confirms additional share purchases in hopes 'to propose shareholder resolutions and submit formal shareholder questions'),YUME +2.1% (Zhengxu He discloses 5.2% passive stake in 13G filing; director of co also disclosed purchase of 20k shares), ZUMZ +1.8% (AEO peer), FFIC +1.8% (announced 1 mln share stock repurchase program), ANF +1.6% (AEO peer), SAVE +1.6% (positve commentary on Mad Money), GNC +1.3% (director disclosed purchase of 30k shares), ACHN +1% (granted U.S. patent for ACH-3102 and structurally related NS5A inhibitors; patent term to last until 2032), NOK +0.9% (Michael Halbherr to step down as CEO of HERE and as a member of the Nokia Group Leadership Team ), CELG +0.7% (Celgene and Bristol-Myers Squibb (BMY) enter clinical collaboration agreement to evaluate immunotherapy and chemotherapy combination regimen), WPX +0.6% (positve commentary on Mad Money), DAL +0.5% (positve commentary on Mad Money), HA +0.4% (positve commentary on Mad Money).
Analyst comments: TNP +2% (upgraded to Overweight from Equal-Weight at Morgan Stanley), CMCM +1.7% (target raised to $30 at Oppenheimer), JBLU +1.4% (upgraded to Outperform from Mkt Perform at Cowen), DNKN +1.2% (upgraded to Overweight from Equal Weight at Barclays ), PNRA +0.9% (upgraded to Overweight from Equal Weight at Barclays), ILMN +0.9% (upgraded to Outperform from Neutral at Wedbush).#
In reaction to strong earnings/guidance: AEO +11.7%, ZPIN +10.2%, LITB +6.1%, HAIN +4.1%, GLOG +3.6%, EJ +3.5%, EJ +3.5%, SPLS +3.3%, PETM +3.2%, EV +1.7%,.
M&A news: FCS +3.9% (reports Infineon (IFNNY) may be looking to acquire US co, no company mentioned), TMUS +0.7% (Iliad SA (ILIAY) seeks help to make another TMUS bid, according to NYPost).
Select metals/mining stocks trading higher: BHP +1.2%, GFI +1.2%, HK +1.1%, RIO +0.9%.
Other news: FOLD +20.4% (announces positive Phase 3 data From Fabry Monotherapy study), DGLY +12.3% (following 90%+ move higher yesterday; attributed to police body camera demand), PETM +3.2% (announced acquisition of Pet360; announced exploration of strategic alternatives; co also reported earnings), CVV +3.2% (co receives an order in excess of $2.75 mln from a major aviation component supplier to design and build a CVD system for coating fiber), LRAD +3.1% (may be body camera related play, TASR and DGLY have also made notable upside moves recently), EXXI +2.5% (positve commentary on Mad Money), SEAS +2.2% (PETA confirms additional share purchases in hopes 'to propose shareholder resolutions and submit formal shareholder questions'),YUME +2.1% (Zhengxu He discloses 5.2% passive stake in 13G filing; director of co also disclosed purchase of 20k shares), ZUMZ +1.8% (AEO peer), FFIC +1.8% (announced 1 mln share stock repurchase program), ANF +1.6% (AEO peer), SAVE +1.6% (positve commentary on Mad Money), GNC +1.3% (director disclosed purchase of 30k shares), ACHN +1% (granted U.S. patent for ACH-3102 and structurally related NS5A inhibitors; patent term to last until 2032), NOK +0.9% (Michael Halbherr to step down as CEO of HERE and as a member of the Nokia Group Leadership Team ), CELG +0.7% (Celgene and Bristol-Myers Squibb (BMY) enter clinical collaboration agreement to evaluate immunotherapy and chemotherapy combination regimen), WPX +0.6% (positve commentary on Mad Money), DAL +0.5% (positve commentary on Mad Money), HA +0.4% (positve commentary on Mad Money).
Analyst comments: TNP +2% (upgraded to Overweight from Equal-Weight at Morgan Stanley), CMCM +1.7% (target raised to $30 at Oppenheimer), JBLU +1.4% (upgraded to Outperform from Mkt Perform at Cowen), DNKN +1.2% (upgraded to Overweight from Equal Weight at Barclays ), PNRA +0.9% (upgraded to Overweight from Equal Weight at Barclays), ILMN +0.9% (upgraded to Outperform from Neutral at Wedbush).#